Welcome to our dedicated page for Select Medical news (Ticker: SEM), a resource for investors and traders seeking the latest updates and insights on Select Medical stock.
Select Medical Holdings Corporation reports company developments for a healthcare operator focused on critical illness recovery hospitals, rehabilitation hospitals and outpatient rehabilitation clinics in the United States. Recurring updates cover operating and financial results, business outlook, cash dividends, segment performance and healthcare regulatory matters tied to its hospital and clinic network.
News about SEM also includes capital-structure disclosures, material agreements, shareholder voting matters and governance actions. Corporate updates may address completed portfolio changes, such as the Concentra distribution, and related discontinued-operations reporting.
Select Medical (NYSE: SEM) reported Q1 2026 results and declared a cash dividend. Revenue rose 5.0% to $1,421.5M, while income from operations fell to $98.4M and net income fell to $63.8M. Adjusted EBITDA was $141.6M. The board declared a cash dividend of $0.0625 per share payable on or about May 28, 2026.
The company entered a merger agreement providing $16.50 per share in cash upon closing; regulatory and shareholder approvals remain required and completion is expected mid-2026.
Select Medical (NYSE: SEM) announced the Hart-Scott-Rodino waiting period for the proposed acquisition by a WCAS XIV subsidiary and a consortium led by Robert A. Ortenzio and Martin F. Jackson expired at 11:59 p.m. ET on April 27, 2026.
The Merger remains subject to Select Medical shareholder approval, including a majority of shares not held by the Consortium, and other customary closing conditions, with closing expected mid-2026.
Select Medical Holdings Corporation (NYSE: SEM) will release first quarter 2026 financial results for the period ended March 31, 2026 on Thursday, April 30, 2026 after market close and will host a webcast conference call on Friday, May 1, 2026 at 9:00 AM ET.
The live webcast and replay will be available on the company website; telephone participants may pre-register to obtain a dial-in number and passcode. As of December 31, 2025, Select Medical operated 104 critical illness recovery hospitals, 38 rehabilitation hospitals, and 1,917 outpatient clinics across 39 states and DC.
Summary not available.
Summary not available.
Summary not available.
Select Medical (NYSE: SEM) agreed to be acquired by a consortium led by Robert A. Ortenzio, Martin F. Jackson and Welsh, Carson, Anderson & Stowe for $16.50 per share in cash, implying an enterprise value of $3.9 billion. The price represents ~18% and ~25% premiums to specified prior prices.
The Special Committee and disinterested directors unanimously approved the Merger Agreement. Certain insiders will roll approximately 11.8% of outstanding shares into the surviving parent. Closing is expected mid 2026, subject to shareholder and regulatory approvals; the company will deregister and go private upon completion.
Select Medical (NYSE: SEM) reported Q4 2025 revenue of $1,396.6M (+6.4%) and FY2025 revenue of $5,452.8M (+5.1%). Q4 income from continuing operations rose to $37.7M; FY income was $214.5M. Adjusted EBITDA was $104.7M (Q4) and $493.2M (FY). The board declared a $0.0625 per-share cash dividend payable ~March 12, 2026, and authorized a $1.0B repurchase program. The company issued 2026 outlook: revenue $5.6–5.8B, Adjusted EBITDA $520–540M, and EPS $1.22–1.32. A take-private proposal from Executive Chairman Robert Ortenzio is under Special Committee review.
Select Medical (NYSE:SEM) and the Philadelphia Eagles announced a multi-year extension renewing NovaCare Rehabilitation as the team's Official Physical Therapy Partner, continuing a 25-year founding partnership.
The agreement names NovaCare as a presenting sponsor for digital fan content, in-stadium signage and videoboards, radio spots, gameday notifications, and continued community involvement including the Eagles Autism Challenge.
Select Medical Holdings (NYSE: SEM) will release fourth quarter and full year results for the period ended December 31, 2025 on February 19, 2026 after market close and will host a business outlook conference call on February 20, 2026 at 9:00 AM ET.
The live webcast and replay are available via the company website; telephone participants may pre-register to receive dial-in numbers and a passcode. As of December 31, 2025, Select Medical operated 104 critical illness recovery hospitals, 38 rehabilitation hospitals, and 1,917 outpatient rehabilitation clinics across 39 states and the District of Columbia.